Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

What to Expect From Pfizer's Next Quarterly Earnings Report

Valued at a market cap of $152.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company dedicated to advancing healthcare through discovering, developing, manufacturing, and distributing innovative medicines and vaccines. The company's extensive portfolio encompasses products like Eliquis, Comirnaty, and Paxlovid, addressing worldwide health challenges. The New York-based company is expected to announce its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4. 

Ahead of this event, analysts expect the drugmaker to report a profit of $0.48 per share, up significantly from $0.10 per share in the year-ago quarter. The company has surpassed Wall Street's earnings estimates in the last four quarters. In Q3, PFE exceeded the consensus EPS estimate by 65.6%.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.